CEO Daniel Virnich highlighted a strong start to the year, reporting "revenue for Q1 increased by 10% versus the prior year period," mainly driven by robust performance in the retail Pharmacy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback